from Reuters: Health News http://ift.tt/2zSglgI
Tuesday, 31 October 2017
AstraZeneca plans new pivotal lung cancer trial with Incyte
LONDON (Reuters) - AstraZeneca is stepping up its bet on immunotherapy combination treatments to fight lung cancer by signing a deal with Incyte under which the two companies will start a final-stage Phase III clinical trial next year.
from Reuters: Health News http://ift.tt/2zSglgI
from Reuters: Health News http://ift.tt/2zSglgI
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment